Cargando…
Comparison of Two Analytical Platforms for CSF Biomarkers of Alzheimer's Disease
Cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) are currently being assessed with two different assays. Our objective was to study if there is a correlation between values obtained by both techniques, to compare their validity and search for conversion factor between values obt...
Autores principales: | Monge-Argilés, Jose Antonio, Muñoz-Ruiz, Carlos, Sánchez-Payá, José, Gasparini Berenguer, Ruth, Blanco Cantó, Maria Empar, Leiva-Santana, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058141/ https://www.ncbi.nlm.nih.gov/pubmed/24971348 http://dx.doi.org/10.1155/2014/765130 |
Ejemplares similares
-
Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
por: Monge-Argilés, J. A., et al.
Publicado: (2016) -
Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
por: Monge-García, Victoria, et al.
Publicado: (2021) -
Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023) -
Pre‐analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
por: Hansson, Oskar, et al.
Publicado: (2020) -
CSF Biomarkers for Alzheimer's Disease Diagnosis
por: Anoop, A., et al.
Publicado: (2010)